Author
Austin Kline
Founder & Lead Analyst, Osiris Kapital
Who is Austin Kline?
Austin Kline is a long-term investor and the founder of Osiris Kapital. He built it to answer company questions from official filings first. Business fundamentals decide the view. Price charts only help with timing.
How are these reports made?
Reports are drafted with AI assistance from stored company filings and reported financial figures. Austin sets the research rules every report follows and corrects reports when errors are found. Figures come from the filings and data providers named on each company page. Read the full methodology.
Reports by Austin Kline
- Vail Resorts: Forensic Investigation of Epic Pass Economics, Leverage, and Valuation
- IonQ Valuation and Commercialization: Financial Reality Versus Market Expectations
- Sony Group: Sum-of-the-Parts Valuation and Conglomerate Transformation
- Stryker's ROIC Dynamics: The Balance Sheet Drag of Serial M&A
- Stryker Corporation: Fundamental Moat Analysis and Intrinsic Valuation
- Zillow Group: Platform Dominance Versus Housing Market Headwinds
- E9Pay IPO Analysis: Remittance Economics and Valuation Realities
- Sony Group Corporation: Sum-of-the-Parts Valuation and Conglomerate Discount Analysis
- NVIDIA's $279 Billion Supply Commitments and Hyperscaler Exposure: Contractual Risk Analysis
- Sirius XM Holdings: Valuation, Debt Leverage, and Structural Headwinds
- Anthropic Valuation Framework: Frontier AI Unit Economics and Fixed Infrastructure Commitments
- American Airlines: Capital Structure, Free Cash Flow, and Structural Headwinds
- Evaluating Mobile Ad-Tech and Performance Marketing Platforms: A Fundamental Framework
- Institutional Capitulation vs. Permanent Impairment: Assessing Volume Profile Analysis
- Related-Party SPAC Transactions and Fiduciary Constraints: Research Alliance Corp V
- Research Alliance Corporation V: Structural Analysis and Sponsor Economics in Healthcare SPACs
- Arxis Investment Research: Valuation, Leverage, and Roll-Up Strategy
- Miller Industries: Fundamental Valuation and Earnings Cyclicality Analysis
- Chinese Hyperscalers and Silicon Independence: Alibaba, Tencent, and the CANN Defense
- NVIDIA Supply Commitments and Purchase Order Structure: Financial Analysis
- Silicon Dependency and Pricing Power: Analyzing Huawei Ascend in Cloud Computing
- Alibaba Cloud AI Pricing Power and Huawei Ascend Competition
- Aviation Economics: Regulatory Flight Constraints and Legacy Carrier Unit Revenues
- U.S. Airlines and Air Traffic Control Inefficiencies: Operational Friction and Margin Drag
- Alibaba Group: Capital Reinvestment, Cash Flow Deterioration, and Valuation
- Tesla Energy Storage: Assessing Megapack Reliance on Related-Party Sales to xAI
- SHF Holdings and PCCU Alliance: Contractual Default and Termination Covenants
- SHF Holdings (SHFS): Financial Distress and the Cannabis Banking Paradox
- Onfolio Holdings: Micro-Cap Digital Aggregation and the Corporate Overhead Trap
- T3 Defense: Micro-Cap Defense Contractor Profile and Capital Structure Risks
- Onto Innovation: Advanced Packaging Metrology and Valuation Analysis
- Industrias Bachoco: Operational Moats, Normalized Earnings, and Privatization Dynamics
- Aviation Network Outages and Operating Leverage: Margin Risk Analysis
- Strategy Inc: Debt Structure Covenants and Bitcoin Liquidation Mechanics
- Strategy Inc.: Capital Structure Stress and Forced Selling Mechanics
- Index Exclusion and Capital Structure Stress: Strategy Inc. Case Study
- Anthropic's Infrastructure Commitments: Free Cash Flow and Operational Leverage Analysis
- Anthropic's Compute Purchase Commitments: Hyperscaler Obligations Analysis
- Eli Lilly's Manufacturing Moat: Vertical Integration and Fill-Finish Capex Acceleration
- Eli Lilly Corporate Governance: Board Interlocks and Peptide CDMO Exposure
- Eli Lilly & Co.: Insider Transactions, Governance Networks, and Strategic Affiliations
- Catalyst Pharmaceuticals: Agamree Commercial Ramp and Firdapse Patent Vulnerabilities
- Catalyst Pharmaceuticals: Patent Litigation Vulnerability and Franchise Durability
- Rare Disease Biopharma M&A: Navigating the 2028 Patent Cliff
- Undervalued Global Therapeutics and Pharmaceuticals: Deep-Value Clinical and Commercial Assets
- NVIDIA Leadership Succession: Incentives for Maintaining the Status Quo
- NVIDIA: Governance, Geopolitics, and Key-Person Risk
- Oracle's Cloud Infrastructure Expansion: Capital Intensity, Financing Structure, and Leverage
- Palantir Technologies: Commercial Acceleration, Asset-Light Margins, and Persistent Share Dilution
- Broadcom and UCIe: Assessing SerDes Moats and Interconnect Economics
- Custom ASIC Packaging Risk Allocation: Broadcom vs. Alphabet
- Hyperscaler Custom ASICs vs. AMD: Absorbing TSMC CoWoS Packaging Capacity
- TSMC Advanced Packaging Fungibility: Investment Research
- NVIDIA Supply Commitments: Contractual Terms and Downside Exposure
- Nabtesco Corporation: Motion Control Economics and Industrial Automation Moat